CI 966

Known as: CI-966 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1990-2005
01219902005

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
In a recent study, EF1502 [N-[4,4-bis(3-methyl-2-thienyl)-3butenyl]-3-hydroxy-4-(methylamino)-4,5,6,7-tetrahydrobenzo [d]isoxazol… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2001
2001
On the basis of the SAR of a series of known gamma-aminobutyric acid (GABA) uptake inhibitors, including 4 (SKF 89976), new… (More)
Is this relevant?
Review
2000
Review
2000
It has been shown that enhancing the function of the major inhibitory neurotransmitter GABA decreases glutamatergic activity in… (More)
Is this relevant?
1995
1995
1. Cerebral ischemia of 5 min duration was induced in unanesthetized gerbils by bilateral occlusion of the carotid arteries. 2… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
gamma-Aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the mammalian brain. The synaptic action of GABA is… (More)
Is this relevant?
1994
1994
gamma-Aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the mammalian central nervous system. Molecular… (More)
Is this relevant?
1994
1994
The discriminative stimulus effects of indirect-acting GABAergic drugs were compared to those of pentobarbital (PB) and midazolam… (More)
Is this relevant?
1993
1993
CI-966 exhibits anticonvulsant properties in various animal models. The drug acts by inhibiting synaptic uptake of γ-aminobutyric… (More)
Is this relevant?
1993
1993
Single-dose administration of 50 mg of 1-[2-[bis[4- (trifluoromethyl)phenyl]methoxy]ethyl]-1,2,5,6-tetrahydro-3… (More)
Is this relevant?
1990
1990
A new potent, blood-brain barrier permeable gamma-aminobutyric acid (GABA) uptake blocker, 1-[2-[bis[4-(trifluoromethyl)-phenyl… (More)
Is this relevant?